Literature DB >> 30411260

Minimal Residual Disease in Head and Neck Cancer and Esophageal Cancer.

Christoph Sproll1, Georg Fluegen2, Nikolas H Stoecklein3.   

Abstract

Malignant epithelial tumors of the upper digestive tract are a major cause of cancer-related death worldwide. The most common of these cancers are head and neck squamous cell carcinomas (HNSCC) and esophageal cancers (EC), which are both characterized by early dissemination and poor prognosis. Although patients with early detected cancers can be subjected to multimodal therapies with curative intention, they are endangered by lethal relapses that frequently occur. These relapses originate from minimal residual cancer (MRD) cells that can only be traced by highly sensitive molecular methods as rare disseminated tumor cells (DTC). The aim of this chapter is to comprehensively inform the reader about the detection, the mode of spread, the clinical relevance, and the biology of DTCs in HNSCC and EC. A better understanding of DTCs will be key to suppress progression of the upper digestive tract cancers more effectively.

Entities:  

Keywords:  Bone marrow; CCDN1; DTC; EGFR; Esophageal cancers; Head and neck squamous cell carcinoma; Lymph node; MRD; MYC; TP53; Whole genome amplification; Whole trascriptome amplification

Mesh:

Year:  2018        PMID: 30411260     DOI: 10.1007/978-3-319-97746-1_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  Elucidating minimal residual disease of paediatric B-cell acute lymphoblastic leukaemia by single-cell analysis.

Authors:  Yingchi Zhang; Shicheng Wang; Jingliao Zhang; Chao Liu; Xinqi Li; Wenbo Guo; Yongjuan Duan; Xiaoyan Chen; Suyu Zong; Jiarui Zheng; Yixuan Wu; Xiaoli Chen; Xuelian Cheng; Yanxia Chang; Yue Wang; Feng Ding; Wenyu Yang; Xiaojuan Chen; Ye Guo; Li Zhang; Yumei Chen; Yao Zou; Xiaofan Zhu; Jin Gu; Tao Cheng
Journal:  Nat Cell Biol       Date:  2022-02-10       Impact factor: 28.213

2.  Genetic analysis of single disseminated tumor cells in the lymph nodes and bone marrow of patients with head and neck squamous cell carcinoma.

Authors:  Karl Christoph Sproll; Lara K Schorn; Benedikt Reising; Sarah Schumacher; Julian Lommen; Norbert R Kübler; Wolfram Trudo Knoefel; Manfred Beier; Rui P Neves; Bianca Behrens; Kai Horny; Nikolas H Stoecklein
Journal:  Mol Oncol       Date:  2021-10-31       Impact factor: 6.603

3.  An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy.

Authors:  Bassem D Khalil; Roberto Sanchez; Tasrina Rahman; Carolina Rodriguez-Tirado; Stefan Moritsch; Alba Rodriguez Martinez; Brett Miles; Eduardo Farias; Mihaly Mezei; Ana Rita Nobre; Deepak Singh; Nupura Kale; Karl Christoph Sproll; Maria Soledad Sosa; Julio A Aguirre-Ghiso
Journal:  J Exp Med       Date:  2021-11-23       Impact factor: 17.579

4.  A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.

Authors:  Henrik Schinke; Enxian Shi; Zhongyang Lin; Tanja Quadt; Gisela Kranz; Jiefu Zhou; Hongxia Wang; Julia Hess; Steffen Heuer; Claus Belka; Horst Zitzelsberger; Udo Schumacher; Sandra Genduso; Kristoffer Riecken; Yujing Gao; Zhengquan Wu; Christoph A Reichel; Christoph Walz; Martin Canis; Kristian Unger; Philipp Baumeister; Min Pan; Olivier Gires
Journal:  Mol Cancer       Date:  2022-09-08       Impact factor: 41.444

5.  A cuproptosis and copper metabolism-related gene prognostic index for head and neck squamous cell carcinoma.

Authors:  Shuaiyuan Zhang; Lujin Zhang; Huanzi Lu; Yihuan Yao; Xiaoyong Liu; Jingsong Hou
Journal:  Front Oncol       Date:  2022-08-22       Impact factor: 5.738

6.  Esophageal Cancer Associated Immune Genes as Biomarkers for Predicting Outcome in Upper Gastrointestinal Tumors.

Authors:  Chuanhui Zhu; Qianqian Xia; Bin Gu; Mengjing Cui; Xing Zhang; Wenjing Yan; Dan Meng; Siyuan Shen; Shuqian Xie; Xueliang Li; Hua Jin; Shizhi Wang
Journal:  Front Genet       Date:  2021-07-19       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.